Prudential Financial
LRMR icon

Prudential Financial’s Larimar Therapeutics LRMR Stock Holding History

Prudential Financial’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$148K Buy
+32,793
New +$131K ﹤0.01% 2186
2025
Q4 		– Sell
-38,091
Closed -$123K – 2342
2025
Q3 		$123K Buy
+38,091
New +$143K ﹤0.01% 2262
2019
Q1 		– Sell
-1,099
Closed -$65K – 2450
2018
Q4 		$65K Buy
+1,099
New +$108K ﹤0.01% 2326

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Prudential Financial's LRMR Position: Q1 2026 in Review

Prudential Financial opened a new position in Larimar Therapeutics (LRMR) in Q1 2026: 32,793 shares worth $148K. The stake represents ﹤0.01% of the portfolio and ranks #2186 among its holdings. This is a return to the name: Prudential Financial previously reported a position in LRMR as recently as Q3 2025.

Prudential Financial first reported a position in LRMR in Q4 2018 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Prudential Financial held 32,793 shares of Larimar Therapeutics worth $148K as of Q1 2026.
  • Larimar Therapeutics was a new Prudential Financial position in Q1 2026.
  • Larimar Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2186 holding.
  • Prudential Financial first reported a position in Larimar Therapeutics in Q4 2018 and has held it in 3 quarters since.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.